Claeys T - Search Results

1

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.

Dhondt B, De Bleser E, Claeys T, Buelens S, Lumen N, Vandesompele J, Beckers A, Fonteyne V, Van der Eecken K, De Bruycker A, Paul J, Gramme P, Ost P. Dhondt B, et al. Among authors: claeys t. World J Urol. 2019 Dec;37(12):2557-2564. doi: 10.1007/s00345-018-2609-8. Epub 2018 Dec 21. World J Urol. 2019. PMID: 30578441

2

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.

Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, De Vos F, Huysse W, Hautekiet A, Maes G, Ost P. Decaestecker K, et al. Among authors: claeys t. Radiat Oncol. 2014 Jun 12;9:135. doi: 10.1186/1748-717X-9-135. Radiat Oncol. 2014. PMID: 24920079 Free PMC article.

3

Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.

Claeys T, Van Praet C, Lumen N, Ost P, Fonteyne V, De Meerleer G, Lambert B, Delrue L, De Visschere P, Villeirs G, Decaestecker K. Claeys T, et al. Biomed Res Int. 2015;2015:198543. doi: 10.1155/2015/198543. Epub 2015 Jan 28. Biomed Res Int. 2015. PMID: 25695051 Free PMC article.

4

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire.

Devos J, Van Praet C, Decaestecker K, Claeys T, Fonteyne V, Decalf V, De Meerleer G, Ost P, Lumen N. Devos J, et al. Among authors: claeys t. Acta Clin Belg. 2015 Aug;70(4):272-9. doi: 10.1179/2295333715Y.0000000015. Epub 2015 Mar 27. Acta Clin Belg. 2015. PMID: 25816107

5

Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.

Poelaert F, Kumps C, Lumen N, Verschuere S, Libbrecht L, Praet M, Rottey S, Claeys T, Ost P, Decaestecker K, De Meerleer G, Van Praet C. Poelaert F, et al. Among authors: claeys t. Urol Int. 2017;99(2):222-228. doi: 10.1159/000455158. Epub 2017 Jan 5. Urol Int. 2017. PMID: 28052297

6

Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

Poelaert F, Fonteyne V, Ost P, De Troyer B, Decaestecker K, De Meerleer G, De Visschere P, Claeys T, Dhondt B, Lumen N. Poelaert F, et al. Among authors: claeys t. Strahlenther Onkol. 2017 Jun;193(6):444-451. doi: 10.1007/s00066-016-1094-5. Epub 2017 Jan 18. Strahlenther Onkol. 2017. PMID: 28101585 English.

7

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies.

Claeys T, Lumen N, Kumps C, Praet M, De Meerleer G, Rottey S, Ost P, Devisschere P, Villeirs G, Fonteyne V, Decaestecker K. Claeys T, et al. Urol Oncol. 2017 Apr;35(4):152.e13-152.e22. doi: 10.1016/j.urolonc.2016.10.013. Epub 2017 Jan 30. Urol Oncol. 2017. PMID: 28153420

8

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.

De Bruycker A, Lambert B, Claeys T, Delrue L, Mbah C, De Meerleer G, Villeirs G, De Vos F, De Man K, Decaestecker K, Fonteyne V, Lumen N, Ameye F, Billiet I, Joniau S, Vanhaverbeke F, Duthoy W, Ost P. De Bruycker A, et al. Among authors: claeys t. BJU Int. 2017 Dec;120(6):815-821. doi: 10.1111/bju.13938. Epub 2017 Jul 16. BJU Int. 2017. PMID: 28646594

9

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, Lambert B, Delrue L, Bultijnck R, Claeys T, Goetghebeur E, Villeirs G, De Man K, Ameye F, Billiet I, Joniau S, Vanhaverbeke F, De Meerleer G. Ost P, et al. Among authors: claeys t. J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14. J Clin Oncol. 2018. PMID: 29240541 Clinical Trial.

10

Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction.

Buelens S, Claeys T, Dhondt B, Poelaert F, Vynck M, Yigit N, Thas O, Ost P, Vandesompele J, Lumen N, Kumps C. Buelens S, et al. Among authors: claeys t. Clin Genitourin Cancer. 2018 Jun;16(3):197-205.e5. doi: 10.1016/j.clgc.2017.12.008. Epub 2017 Dec 29. Clin Genitourin Cancer. 2018. PMID: 29366632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters